Compare Medpace Holdings Inc (MEDP) vs Abrdn Physical Platinum Shares ETF (PPLT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Abrdn Physical Platinum Shares ETF — how do they compare? Medpace Holdings Inc trades at $612.05 (market cap $16.82B), while Abrdn Physical Platinum Shares ETF trades at $15.25 (market cap $1.93B). The key difference: Medpace Holdings Inc is far larger — about 8.7× Abrdn Physical Platinum Shares ETF's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Abrdn Physical Platinum Shares ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and Abrdn Physical Platinum Shares ETF for 42 Days on average.
| MEDP | PPLT | |
|---|---|---|
Market Cap | $16.82B | $1.93B |
Volume | 223,093 | 1,698,523 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $630.19 | $25.23 |
52-Week Low | $393.42 | $13.73 |
Typical Hold Time | 14 Days | 42 Days |
Enterprise Value | $16.44B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $612.05, up 1.29% today, near its consensus price target of $620.44. The stock shows strong profitability with a 17.67% net margin and has beaten earnings estimates for the last three quarters. Technical indicators are neutral overall, with support at $595 and resistance at $612. Recent news highlights CEO stock sales and institutional position changes, while the company prepares to report Q3 2026 results on October 21.
Outlook remains positive given consistent earnings beats and projected revenue growth to $2.8B in 2026. Risks include high valuation multiples (P/E 35.41) and insider selling. Analyst consensus is cautious with 79% hold ratings, suggesting limited near-term upside but solid fundamental support for long-term holders.
PPLT, the abrdn Physical Platinum Shares ETF, trades at $15.25 with a 3.18% daily gain, though technical indicators signal a bearish trend with moving averages unanimously negative. The ETF's fundamental metrics are unavailable in standard financial databases as it tracks physical platinum rather than operating as a traditional company. Recent news highlights platinum's underperformance relative to other precious metals, with mixed signals between bearish term structure and potential seasonal recovery opportunities.
The outlook remains cautious with technical weakness offset by potential catch-up trade opportunities. Key risks include platinum supply dynamics and precious metals market volatility, while the neutral oscillator readings suggest limited near-term momentum. Investment appeal hinges on macroeconomic factors driving platinum demand rather than traditional equity fundamentals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Abrdn Physical Platinum Shares ETF
PPLT is a physically-backed ETF designed to track the spot price of platinum, less the Trust's expenses. It holds physical platinum bullion in secure vaults, providing investors with a liquid and cost-effective way to access the platinum market without the logistical challenges of direct ownership.
Read more on PPLT →
